Abstract
Approximately one in ten women undergo pelvic reconstructive surgery during their lifetime, and almost one third have preoperative anemia. Knowledge of strategies for reduction of blood loss at vaginal surgery may optimize post-operative outcomes. We aimed to evaluate the effectiveness of tranexamic acid and other hemostatic agents in reduction of surgical blood loss at vaginal reconstructive surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
